FDA inspection

Novartis Pharmaceuticals Corp.: FDA inspection ending Feb 11, 2014

FDA inspection 866692 · No Action Indicated (NAI) · Suffern, NY

Key facts

Inspection ID 866692
Firm Novartis Pharmaceuticals Corp.
FEI number 2416082
Address 25 Old Mill Rd
City Suffern
State NY
ZIP 10901
Country United States
Fiscal year 2014
Inspection end date Feb 11, 2014
Classification No Action Indicated (NAI)
Project area Drug Quality Assurance
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • No Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections